Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
Syringe (prefilled, single chamber, 1/2 liquid)
[{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8de96/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8de96/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8de97/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8de97/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8de98/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8de98/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8de99/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8de99/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8de9a/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8de9a/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8de9b/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8de9b/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8de9c/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8de9c/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8de9d/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8de9d/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8de9e/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8de9e/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8de9f/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8de9f/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8dea0/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8dea0/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8dea1/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8dea1/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8dea2/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8dea2/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8dea3/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8dea3/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8dea4/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8dea4/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8dea5/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8dea5/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8dea6/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8dea6/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8dea7/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8dea7/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8dea8/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8dea8/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8dea9/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8dea9/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8deaa/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8deaa/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8deab/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8deab/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8deac/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8deac/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8dead/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8dead/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8deae/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8deae/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8deaf/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8deaf/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8deb0/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8deb0/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8deb1/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8deb1/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8deb2/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8deb2/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8deb3/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8deb3/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8deb4/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8deb4/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8deb5/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8deb5/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8deb6/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8deb6/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8deb7/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8deb7/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8deb8/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8deb8/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8deb9/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8deb9/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8deba/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8deba/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8debb/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8debb/6793ec381d3750e8e021a53c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793ec783f01f03526a8debc/6793ec381d3750e8e021a53c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793ec783f01f03526a8debc/6793ec381d3750e8e021a53c.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
.png)
SIGN UP FREEKeywords
syringe,prefilled,non-capped,single chamber,injection,medication,drug delivery,patient,Xolair,Leqvio,inclisiran,Entresto,sacubitril,valsartan,Kisqali,ribociclib,Cosentyx,secukinumab,Gilenya,fingolimod,Aimovig,erenumab,Lucentis,ranibizumab,Zolgensma,onasemnogene abeparvovec,allergic forms of asthma,nasal polyps,urticaria,hives,immunoglobulin E-mediated food allergy,healthcare,dosage,precise,sterile,ready-to-use,subcutaneous,intramuscular,intravenous,administration,packaging,preservation,needle,autoinjector,manual,disposable,reusable,compartmentalized,bifurcated,encapsulated,compartment,mixed,solution,lyophilized,reconstitution,activation,plunger,cartridge,ampoule,actuator,membrane,biological,pharmaceutical,chemistry,life sciences,medicine,therapeutics,diagnostics,research,clinical,pharmacology,biotechnology,biochemistry,molecular biology,immunology,oncology,endocrinology,rheumatology,cardiology,hematology,neurology,microbiology,virology,toxicology,dermatology,gastroenterology,nephrology,urology,pulmonology,gavage,1/2,half,liquid,half full,half filled,filled,full,proj-creative-abx-24q2,proj-creative-abx-24q2-[novartis],syringe
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Related Categories
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
